{"tid":2239155,"cid":5,"subCid":10,"title":"哈佛教授被起訴後自資辯護    告大學違反合約","createTime":"2020-10-11T16:29:23.000Z","updateTime":"2020-10-11T16:39:22.000Z","uid":225931,"like":1,"dislike":4,"uniUserReply":2,"replies":[{"pid":"49b2d5bd77d365737c2b897e4054b544a26c3e4c","tid":2239155,"uid":225931,"like":0,"dislike":0,"score":0,"citedBy":0,"replyTime":"2020-10-11T16:29:23.000Z","msg":"美國哈佛大學化學和生化系前主任利伯（Dr. Charles Lieber）因向聯邦政府隱瞞參與中國「千人計劃」而被起訴，利伯周五向哈佛大學提出訴訟，表示自己在被司法部起訴後，遭到大學拋棄，認為這是違反合約。<br />\n<br />\n利伯的律師穆凱西（Marc L. Mukasey）稱利伯患有「濾泡性淋巴癌」（Follicular lymphoma），這屬一種血癌。訴訟指哈佛多年來一直從利伯的研究中獲利，帶來1,000萬美元（7,800萬港元）的研究經費，卻在後來「不顧利伯教授的困境，拒絕他的晉升和賠償請求，與之保持距離」。"},{"pid":"2920e973b10c12baf27ad9d285f90658415693c4","tid":2239155,"uid":279357,"like":1,"dislike":1,"score":0,"citedBy":0,"replyTime":"2020-10-11T16:39:22.000Z","msg":"利用完無錢收發脾氣"}]}